Literature DB >> 19947308

Comparing the psychological stress between non-smoking patients and smoking patients who experience abrupt smoking cessation during hospitalization for acute myocardial infarction: a pilot study.

Kathryn A Pfaff1, Maher M El-Masri, Susan M Fox-Wasylyshyn.   

Abstract

BACKGROUND: Stress is an untoward condition in patients with acute myocardial infarction (AMI). Abrupt nicotine withdrawal is associated with increased symptoms of stress. However, little is known about the impact of smoking cessation on the psychological indicators of stress among hospitalized AMI patients.
PURPOSE: In this pilot study we compared the psychological stressors between non-smoking AMI patients and smoking patients who abruptly ceased smoking following admission to the CCU.
METHODS: A cross-sectional survey was piloted on a sample of 57 AMI patients (29 smokers and 28 nonsmokers) on the second day of admission to the CCU. Psychological stress was measured using the Profile of Mood States and the Insomnia Severity Index.
RESULTS: Multivariate analysis of covariance (MANCOVA) suggested that after adjusting for age, smokers experienced significantly higher overall levels of stress than non-smokers (F = 3.13; p = 0.016). Post-hoc analyses suggested that scores of depression (p = 0.033), anxiety (p = 0.007), and anger (p = 0.017) were particularly higher among smokers, as compared to non-smokers. However, the two groups were not different with regard to their scores on fatigue (p = 0.528) and insomnia (p = 0.299).
CONCLUSIONS: Abrupt smoking cessation may expose patients admitted with AMI symptoms to higher levels of psychological stress. Given the potential damaging impact of psychological stressors on the physical outcomes of these patients, these findings demonstrate the need for continued assessment and research related to the management of nicotine withdrawal following AMI.

Entities:  

Mesh:

Year:  2009        PMID: 19947308

Source DB:  PubMed          Journal:  Can J Cardiovasc Nurs        ISSN: 0843-6096


  7 in total

1.  Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline.

Authors:  Daniel Tranel; Ashton McNutt; Antoine Bechara
Journal:  Cogn Behav Neurol       Date:  2012-03       Impact factor: 1.600

2.  Scared for the scar: fearsome impact of acute cardiovascular disease on perceived kinesiophobia (fear of movement).

Authors:  Natale D Brunetti; Antonio Guerra; Riccardo Ieva; Michele Correale; Francesco Santoro; Nicola Tarantino; Matteo Di Biase
Journal:  Clin Cardiol       Date:  2017-03-08       Impact factor: 2.882

3.  Sleep Disturbances in Patients With Coronary Heart Disease: A Systematic Review.

Authors:  Michael Tilling Madsen; Chenxi Huang; Graziella Zangger; Ann Dorthe Olsen Zwisler; Ismail Gögenur
Journal:  J Clin Sleep Med       Date:  2019-03-15       Impact factor: 4.062

Review 4.  Psychological distress related to smoking cessation in patients with acute myocardial infarction.

Authors:  Thyego Mychell Moreira-Santos; Irma Godoy; Ilda de Godoy
Journal:  J Bras Pneumol       Date:  2016 Jan-Feb       Impact factor: 2.624

5.  Sleep disturbance after acute coronary syndrome: A longitudinal study over 12 months.

Authors:  Roland von Känel; Rebecca E Meister-Langraf; Claudia Zuccarella-Hackl; Sarah L F Schiebler; Hansjörg Znoj; Aju P Pazhenkottil; Jean-Paul Schmid; Jürgen Barth; Ulrich Schnyder; Mary Princip
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

6.  Anxiety, depression and methods of stress coping in patients with nicotine dependence syndrome.

Authors:  Tadeusz Pietras; Andrzej Witusik; Michał Panek; Janusz Szemraj; Paweł Górski
Journal:  Med Sci Monit       Date:  2011-05

7.  Short-Term Safety of Nicotine Replacement in Smokers Hospitalized With Coronary Heart Disease.

Authors:  Quinn R Pack; Aruna Priya; Tara C Lagu; Penelope S Pekow; Auras Atreya; Nancy A Rigotti; Peter K Lindenauer
Journal:  J Am Heart Assoc       Date:  2018-09-18       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.